Neomorph Revenue and Competitors
Estimated Revenue & Valuation
- Neomorph's estimated annual revenue is currently $5.4M per year.
- Neomorph's estimated revenue per employee is $77,500
- Neomorph's total funding is $109M.
Employee Data
- Neomorph has 70 Employees.
- Neomorph grew their employee count by 27% last year.
Neomorph's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder, President and CEO | Reveal Email/Phone |
2 | VP, Business Development | Reveal Email/Phone |
3 | VP Chemistry | Reveal Email/Phone |
4 | VP, Data Sciences | Reveal Email/Phone |
5 | VP, Molecular Sciences | Reveal Email/Phone |
6 | Controller | Reveal Email/Phone |
7 | Chief Financial Officer | Reveal Email/Phone |
8 | Director Data Engineering | Reveal Email/Phone |
9 | Senior Director | Reveal Email/Phone |
10 | Associate Director | Reveal Email/Phone |
Neomorph Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.6M | 41 | 5% | N/A | N/A |
#2 | $188.5M | 520 | -1% | N/A | N/A |
What Is Neomorph?
Neomorph is a venture backed biotechnology company based in San Diego, California. The team at Neomorph is building a leading protein degradation company, focusing on ‘molecular glue' degraders. Our mission at Neomorph is to use this technology to solve critical problems in human health by the discovery and development of innovative new medicines against ‘undruggable targets'. The Neomorph team is composed of leaders from the academic and industrial worlds who have demonstrated years of commitment and success in the field, and who remain dedicated to advancing the technology and delivering highly impactful drugs. The Neomorph team is advancing the science and technology of molecular glue drug discovery, while prosecuting a pipeline of projects through clinical development. Neomorph has a key collaboration with the Center for Protein Degradation at the Dana Farber Cancer Institute.
keywords:N/A
$109M
Total Funding
70
Number of Employees
$5.4M
Revenue (est)
27%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Neomorph News
Throughout both Alien prequels, Xenomorph prototypes such as the Deacon or Neomorph were seen, leading to Alien: Covenant's Protomorph.
Neomorph, Inc. to Participate in Upcoming Guggenheim Healthcare Talks Targeted Protein Degradation Day. March 10, 2022 08:00 AM Eastern...
Neomorph, Inc., a San Diego, CA-based biotechnology company, raised $109m in Series A financing. The company intends to use the funds to further develop its platform, advance lead programs, and expand the research team. Deerfield Management Company established Neomorph earlier this year with s ...
San Diego-based Neomorph, a biotech startup focused on protein degradation, said today that it has raised $109M in a Series A funding. The funding came from Deerfield Management. The company said its targeted protein degradation technology is aimed at developing novel therapeutics across a broad ...
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $17M | 70 | 9% | N/A |
#2 | $6.4M | 70 | 21% | N/A |
#3 | $11.3M | 70 | 11% | N/A |
#4 | $17M | 70 | 1% | N/A |
#5 | $9.5M | 70 | -3% | N/A |